Azolmen Cream 30 gr 1%

WARNINGS
The use, especially if prolonged, of medicines for cutaneous use, can give rise to sensitization phenomena; in this case, it is necessary to interrupt the treatment and institute a suitable therapy. The same will be done in case of development of resistant microorganisms. Pediatric population: in very early childhood the medicine should be used only in case of real need '. The drug cream contains cetylstearyl alcohol which can cause local skin reactions (eg contact dermatitis).
PHARMACOTHERAPEUTIC CATEGORY
Topical antifungals.
STORAGE
This medicine does not require any special storage conditions.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the listed excipients.
NAME
AZOLMEN
EXCIPIENTS
Cream: sorbitan monostearate; polysorbate 60; spermaceti; cetylstearyl alcohol; octyldodecanol; benzyl alcohol; purified water. Gel: mixture of ethoxylated fatty alcohols; glycerides of ethoxylated fatty acids; isopropylisostearate; ethyl alcohol; lactic acid; benzyl alcohol; purified water. Skin solution: ethanol; isopropyl myristate. Non-gellable rice starch skin powder.
SIDE EFFECTS
The medicinal cream, gel, solution and powder is perfectly tolerated. Only in rare cases a slight and mostly transitory redness of the skin may arise and more rarely a sense of burning and irritation which usually disappear quickly. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.
PREGNANCY AND BREASTFEEDING
In pregnant women the medicine should be used only in case of real need '.
INDICATIONS
Cream, gel and skin solution: dermatomycosis sustained by dermatophytes (eg. Ringworms), saccharomyces (eg Candida) and other pathogenic fungi (eg Malassezia furfur). Dermatosis caused by superinfections caused by the aforementioned pathogenic fungi and by germs sensitive to the drug. These conditions include plantar and interdigital mycosis of the hand and foot (athlete's foot); onychomycosis, mycosis of the trunk and skin folds, pityriasis versicolor. Skin powder: it is indicated for the treatment of wet mycoses of the skin and skin folds, especially if located in areas usually covered or poorly ventilated (for example: bandage dermatitis, interdigital mycosis) as well as as an adjuvant to the treatment with cream, gel skin solution .
INTERACTIONS
No interactions of bifonazole with other medicines or other forms of interaction have been reported in the literature.
DOSAGE
Cream, gel and skin solution: unless otherwise prescribed, the product should be applied in small quantities on the infected parts with a light massage once a day, preferably in the evening before going to bed. The drug cream and gel are electively indicated for the treatment of uncovered skin areas. The gel medicine, thanks to the refreshing power of its components, is particularly useful in cases where an inflammatory component with a burning sensation and / or skin itching is associated with the current infection. Given the high activity of the product, it is usually sufficient to apply a small amount (eg half a cm of cream or gel) to cover a surface the size of a palm of your hand. The drug cutaneous solution is especially useful for the treatment of skin areas covered by hair as well as fungal infections in correspondence of the skin folds, with the exception of the mucous membranes. The drug cream, gel and cutaneous solution is odorless, does not stain and can be easily removed with water. For the purpose of complete healing, the controlled and sufficiently prolonged use of the product is essential.It is advisable not to interrupt therapy immediately after the disappearance of the acute inflammatory manifestations and subjective symptoms, but to adhere to the following average treatment times, to depending on the type of infection, the extent and location of the infection itself: tinea pedis 3 weeks; tinea corporis, tinea manuum, tinea cruris 2- (3) weeks; pityriasis versicolor 2 weeks; superficial cutaneous candidiasis 2- (4) weeks. The treatment times indicated in brackets refer to forms, in medical opinion, particularly extensive or resistant. Skin powder: the affected skin parts can be sprinkled with the powder, one or more times a day, depending on the degree of humidity and the localization of the mycosis. The skin powder can, on medical advice, be applied as an adjuvant to the cream, gel or skin solution (for example: almat powder , in the evening cream, gel or skin solution). The pulverecutanea can be sprinkled, in case of tinea pedis, in shoes and socks also in order to eliminate the humidity conditions and to avoid reinfections.
ACTIVE PRINCIPLES
Bifonazole.